Assessment of myocardial performance index in late-onset fetal growth restriction

Tran Thao Nguyen Nguyen1, Tomomi Kotani2,3, Kenji Imai3

  • 1Department of Obstetrics and Gynecology, Hue University of Medicine and Pharmacy, Hue University, Hue, Vietnam.

Insights

The myocardial performance index (MPI) is elevated in fetuses with fetal growth restriction (FGR). Increased MPI, along with umbilical arterial pulsatility index (UA-PI), can predict adverse outcomes in late-onset FGR pregnancies.

Area of Science:

  • Perinatology
  • Fetal Cardiology
  • Reproductive Medicine

Background:

  • Fetal growth restriction (FGR) is associated with increased risks of adverse perinatal outcomes.
  • Cardiac dysfunction is increasingly recognized as a component of FGR pathophysiology.
  • The myocardial performance index (MPI) is a sensitive indicator of global biventricular function.

Purpose of the Study:

  • To investigate whether the myocardial performance index (MPI) is elevated in fetuses with late-onset FGR.
  • To determine if increased MPI is associated with adverse pregnancy outcomes in FGR.
  • To explore the relationship between MPI, umbilical arterial pulsatility index (UA-PI), and FGR severity.

Main Methods:

  • Prospective cross-sectional study comparing 73 late-onset FGR fetuses with 97 gestational-age matched controls.
  • Fetal blood flow parameters, including MPI and UA-PI, were measured.
  • FGR fetuses were stratified by growth restriction severity and pregnancy outcome (favorable vs. adverse) for comparative analysis.

Main Results:

  • FGR fetuses exhibited significantly higher MPI and UA-PI values compared to controls.
  • No significant differences in MPI or UA-PI were found between FGR subgroups based on growth restriction severity (<3rd vs. 3rd-10th centiles).
  • Elevated MPI and UA-PI were independently correlated with adverse outcomes in late-onset FGR pregnancies.

Conclusions:

  • Myocardial performance index (MPI) is increased in pregnancies complicated by late-onset FGR.
  • Higher MPI levels, similar to UA-PI, serve as a predictive marker for adverse outcomes in FGR.
  • Clinicians should consider assessing cardiac function using MPI in the management of FGR.